NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
Back to search
Official data from USPTO
MULDIA MULTIPLEXED MOLECULAR DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/07/2025
Trademark type
Combined
Nice classes
10
Filing date
10/18/2023
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
05/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
BARCELONA, ES
Examiner
SHOOR, AMIT
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "MULDIA" with "MUL"and "IA" in blue, with the letter "D" being filled in orange and containing a design of white stylized lines within it, and the stylized words "MULTIPLEXED MOLECULAR DIAGNOSTICS" in orange.
Holders and representatives
Holders
BRILL ENGINES, S.L.
Representatives
Jason L DeFrancesco THE DEFRANCESCO LAW FIRM PLLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Diagnosticexamination and monitoring equipmentmedical diagnostic apparatus for testing biomarkers in bodily fluids and tissuesincluding antibodiesproteinstau proteinnucleic acidsinflammatory molecules such as C-Reactive Protein and Ferritin; medical diagnostic instrumentsmedical diagnostic apparatus for testing biomarkers associated with Alzheimer's diseasefood allergiesophthalmic pathologiesCOVID-19SARS-CoV-2 presence; Tools for medical diagnosismedical diagnostic apparatus for testing biomoleculesincluding small moleculesproteinsantibodiesoligonucleotidesfrom sources such as bloodurinetearswaters and wastewater; Diagnostic apparatus for medical usemedical diagnostic apparatus for testing optical interferometry-based detection of target biomolecules and high-throughput screening of multiple biomarkers; Devices for use in medical diagnosticsmedical diagnostic apparatus for testing biomolecules and antibodies for applications in disease diagnosismonitoringprogression tracking
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2025
PUBO
PUBLISHED FOR OPPOSITION
02/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/09/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/08/2024
GNFR
FINAL REFUSAL E-MAILED
10/08/2024
CNFR
FINAL REFUSAL WRITTEN
10/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2024
GNRT
NON-FINAL ACTION E-MAILED
06/11/2024
CNRT
NON-FINAL ACTION WRITTEN
06/11/2024
DOCK
ASSIGNED TO EXAMINER
06/04/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2023
NWAP
NEW APPLICATION ENTERED
10/21/2023
Continuous trademark protection
Get notified about every new filing that threatens MULDIA MULTIPLEXED MOLECULAR DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.